CC 趋化因子受体与癌症的相关性

佳园 陈(内蒙古医科大学，中国;)
卉 李(内蒙古自治区人民医院肿瘤内科，中国;)

摘要

肺癌在全球范围内，发病率和死亡率皆居高不下，严重威胁着人类健康。近年来，随着对肿瘤微环境和免疫调节机制研究的不断深入，趋化因子受体在癌症发生发展中的作用已逐渐受到广泛的关注。本文深入探讨了CC趋化因子受体与癌症的相关性，涵盖了其在癌症发生发展中的作用机制、对肿瘤细胞生物学行为的影响、在肿瘤微环境中的调节作用以及与免疫治疗的关系等方面。通过对相关研究的综合分析，揭示了CC趋化因子受体在癌症诊断、治疗和预后评估中的潜在价值，同时也指出了目前研究存在的问题和未来的发展趋势。

关键词

CC趋化因子；趋化因子受体；癌症

参考

Hanahan, D. Weinberg, R.A. The hallmarks of cancer[J]. Cell 2000, 100, 57-70.

Hanahan, D. Weinberg, R.A. Hallmarks of cancer: The next generationr[J]. Cell 2011, 144, 646-674.

Liu, Q. Yang, C. Wang, S. Shi, D. Wei, C. Song, J. Lin, X. Dou, R. Bai, J. Xiang, Z. et al. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progressionr[J]. Cell Commun. Signal. 2020, 18, 51.

Wang, Z. Yang, Y. Cui, Y. Wang, C. Lai, Z. Li, Y. Zhang, W. Mustonen, H. Puolakkainen, P. Ye, Y. et al. Tumor-associated macrophages regulate gastric cancer cell invasion and metastasis through TGFβ2/NF-κB/Kindlin-2 axisr[J]. Chin. J. Cancer Res. 2020, 32, 72-88.

Wu, H. Zhang, X. Han, D. Cao, J. Tian, J. Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8r[J]. PeerJ 2020, 8, e8721.

Zlotnik, A. Yoshie, O. Chemokines: A new classification system and their role in immunityr[J]. Immunity 2000, 12, 121-127.

Hughes, C.E. Nibbs, R.J.B. A guide to chemokines and their receptorsr[J]. FEBS J. 2018, 285, 2944-2971.

Uhlén, M. Fagerberg, L. Hallström, B.M. Lindskog, C. Oksvold, P. Mardinoglu, A. Sivertsson, Å.Kampf, C. Sjöstedt, E. Asplund, A. et al. Proteomics. Tissue-based map of the human proteomer[J]. Science 2015, 347, 1260419.

Uhlen, M. Zhang, C. Lee, S. Sjöstedt, E. Fagerberg, L. Bidkhori, G. Benfeitas, R. Arif, M. Liu, Z. Edfors, F.et al. A pathology atlas of the human cancer transcriptomer[J]. Science 2017, 357, eaan2507.

Iannello, A. Thompson, T.W. Ardolino, M. Lowe, S.W. Raulet, D.H. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cellsr[J]. Exp. Med. 2013, 210, 2057-2069.

Lança, T. Costa, M.F. Gonçalves-Sousa, N. Rei, M. Grosso, A.R. Penido, C. Silva-Santos, B. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor bedsr[J]. Immunol. 2013, 190, 6673-6680.

Bartneck, M. Schrammen, P.L. Möckel, D. Govaere, O. Liepelt, A. Krenkel, O. Ergen, C. McCain, M.V. Eulberg, D. Luedde, T. et al. The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Liversr[J]. Cell Mol. Gastroenterol. Hepatol. 2019, 7, 371-390.

Li, F. Kitajima, S. Kohno, S. Yoshida, A. Tange, S. Sasaki, S. Okada, N. Nishimoto, Y. Muranaka, H. Nagatani, N. et al. Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretionr[J]. Cancer Res. 2019, 79, 3903-3915.

Korbecki, J. Grochans, S. Gutowska, I. Barczak, K. Baranowska-Bosiacka, I. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligandsr[J]. nt. J. Mol. Sci. 2020, 21, 7619.

Schulz-Knappe, P. Mägert, H.J. Dewald, B. Meyer, M. Cetin, Y. Kubbies, M. Tomeczkowski, J. Kirchhoff, K. Raida, M. Adermann, K. et al. HCC-1, a novel chemokine from human plasmar[J]. Exp. Med. 1996, 183, 295-299.

Tsou, C.L. Gladue, R.P. Carroll, L.A. Paradis, T. Boyd, J.G. Nelson, R.T. Neote, K. Charo, I.F. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptorr[J]. Exp. Med. 1998, 188, 603-608.

Detheux, M. Ständker, L. Vakili, J. Münch, J. Forssmann, U. Adermann, K. Pöhlmann, S. Vassart, G. Kirchhoff, F. Parmentier, M. et al. Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV propertiesr[J]. Exp. Med. 2000, 192, 1501-1508.

Münch, J. Ständker, L. Pöhlmann, S. Baribaud, F. Papkalla, A. Rosorius, O. Stauber, R. Sass, G. Heveker, N. Adermann, K. et al. Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophagesr[J]. Antimicrob. Agents Chemother. 2002, 46, 982-990.

Struyf, S. Stoops, G. Van Coillie, E. Gouwy, M. Schutyser, E. Lenaerts, J.P. Fiten, P. Van Aelst, I. Proost, P.Opdenakker, G. et al. Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractantsr[J]. Biochemistry 2001, 40, 11715-11722.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i12.22895